Related Experiment Video
Updated: Mar 19, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Absent in melanoma 2 proteins in the development of cancer
1Research Service, Cincinnati VA Medical Center, 3200 Vine Street, ML-151, Cincinnati, OH, 45220, USA. divaker.choubey@uc.edu.
Abstract:
Recent studies utilizing chemical-induced colitis-associated and sporadic colon cancer in mouse models indicated a protective role for absent in melanoma 2 (Aim2) in colon epithelial cells. Accordingly, mutations in the human AIM2 gene have been found in colorectal cancer (CRC), and reduced expression of AIM2 in CRC is associated with its progression. Furthermore, the overexpression of AIM2 protein in human cancer cell lines inhibits cell proliferation. Interferon-inducible Aim2 and AIM2 are members of the PYHIN (PYRIN and HIN domain-containing) protein family and share ~57 % amino acid identity. The family also includes murine p202, human PYRIN-only protein 3, and IFI16, which negatively regulate Aim2/AIM2 functions. Because the CRC incidence and mortality rates are higher among men compared with women and the expression of Aim2/AIM2 proteins and their regulators is dependent upon age, gender, and sex hormones, we discuss the potential roles of Aim2/AIM2 in the development of cancer. An improved understanding of the biological functions of the AIM2 in the development of CRC will likely identify new therapeutic approaches to treat patients.
Insights
Absent in melanoma 2 (Aim2) protein shows a protective role in colon epithelial cells, suggesting its potential as a therapeutic target for colorectal cancer (CRC). Further research into Aim2
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Absent in melanoma 2 (Aim2) is an interferon-inducible PYRIN and HIN domain-containing protein.
- Mutations in the human AIM2 gene and reduced AIM2 expression are linked to colorectal cancer (CRC) progression.
- AIM2 protein overexpression inhibits cancer cell proliferation.
Purpose of the Study:
- To explore the protective role of Aim2 in colon epithelial cells.
- To discuss the potential involvement of Aim2/AIM2 in cancer development, considering age, gender, and hormonal influences.
- To highlight the significance of understanding AIM2's biological functions for CRC therapeutic strategies.
Main Methods:
- Utilized chemical-induced colitis-associated and sporadic colon cancer mouse models.
- Analyzed human colorectal cancer (CRC) data for AIM2 gene mutations and expression levels.
- Examined the effect of AIM2 protein overexpression on human cancer cell lines.
Main Results:
- Absent in melanoma 2 (Aim2) demonstrated a protective effect in colon epithelial cells in mouse models.
- AIM2 gene mutations and reduced AIM2 expression are associated with CRC progression in humans.
- Overexpression of AIM2 protein inhibited proliferation in human cancer cell lines.
Conclusions:
- Aim2 plays a protective role in the colon, and its dysfunction is implicated in colorectal cancer.
- Factors like age, gender, and hormones may influence Aim2/AIM2 expression and function in cancer.
- Elucidating Aim2's role in CRC could lead to novel therapeutic interventions.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

